...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Still waiting for that BETonMACE CKD sub-study 7 months later

jonzobot

in addition to the points you make in your post, depending on trial size, design, endpoints, etc, I believe we will have an opportunity for an early trial halt due to overwhelming efficacy.  So maybe not as long and as expensive as we fear.  I think this is one of the great features/benefits of the BTD...?

Share
New Message
Please login to post a reply